Global CD38 Monoclonal Antibody Drugs Market Insights and Forecast to 2028

Global CD38 Monoclonal Antibody Drugs Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 CD38 Monoclonal Antibody Drugs Product Introduction
1.2 Market by Type
1.2.1 Global CD38 Monoclonal Antibody Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Daretuzumab
1.2.3 Isartuximab
1.2.4 Engineered Toxin Body
1.3 Market by Application
1.3.1 Global CD38 Monoclonal Antibody Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Multiple Myeloma
1.3.3 Diffuse Large B Cell Lymphoma
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global CD38 Monoclonal Antibody Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global CD38 Monoclonal Antibody Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global CD38 Monoclonal Antibody Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global CD38 Monoclonal Antibody Drugs Sales by Region
2.4.1 Global CD38 Monoclonal Antibody Drugs Sales by Region (2017-2022)
2.4.2 Global Sales CD38 Monoclonal Antibody Drugs by Region (2023-2028)
2.5 Global CD38 Monoclonal Antibody Drugs Revenue by Region
2.5.1 Global CD38 Monoclonal Antibody Drugs Revenue by Region (2017-2022)
2.5.2 Global CD38 Monoclonal Antibody Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global CD38 Monoclonal Antibody Drugs Sales by Manufacturers
3.1.1 Global Top CD38 Monoclonal Antibody Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global CD38 Monoclonal Antibody Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of CD38 Monoclonal Antibody Drugs in 2021
3.2 Global CD38 Monoclonal Antibody Drugs Revenue by Manufacturers
3.2.1 Global CD38 Monoclonal Antibody Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by CD38 Monoclonal Antibody Drugs Revenue in 2021
3.3 Global CD38 Monoclonal Antibody Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global CD38 Monoclonal Antibody Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global CD38 Monoclonal Antibody Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global CD38 Monoclonal Antibody Drugs Sales by Type
4.1.1 Global CD38 Monoclonal Antibody Drugs Historical Sales by Type (2017-2022)
4.1.2 Global CD38 Monoclonal Antibody Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global CD38 Monoclonal Antibody Drugs Sales Market Share by Type (2017-2028)
4.2 Global CD38 Monoclonal Antibody Drugs Revenue by Type
4.2.1 Global CD38 Monoclonal Antibody Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global CD38 Monoclonal Antibody Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Type (2017-2028)
4.3 Global CD38 Monoclonal Antibody Drugs Price by Type
4.3.1 Global CD38 Monoclonal Antibody Drugs Price by Type (2017-2022)
4.3.2 Global CD38 Monoclonal Antibody Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global CD38 Monoclonal Antibody Drugs Sales by Application
5.1.1 Global CD38 Monoclonal Antibody Drugs Historical Sales by Application (2017-2022)
5.1.2 Global CD38 Monoclonal Antibody Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global CD38 Monoclonal Antibody Drugs Sales Market Share by Application (2017-2028)
5.2 Global CD38 Monoclonal Antibody Drugs Revenue by Application
5.2.1 Global CD38 Monoclonal Antibody Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global CD38 Monoclonal Antibody Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Application (2017-2028)
5.3 Global CD38 Monoclonal Antibody Drugs Price by Application
5.3.1 Global CD38 Monoclonal Antibody Drugs Price by Application (2017-2022)
5.3.2 Global CD38 Monoclonal Antibody Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America CD38 Monoclonal Antibody Drugs Market Size by Type
6.1.1 North America CD38 Monoclonal Antibody Drugs Sales by Type (2017-2028)
6.1.2 North America CD38 Monoclonal Antibody Drugs Revenue by Type (2017-2028)
6.2 North America CD38 Monoclonal Antibody Drugs Market Size by Application
6.2.1 North America CD38 Monoclonal Antibody Drugs Sales by Application (2017-2028)
6.2.2 North America CD38 Monoclonal Antibody Drugs Revenue by Application (2017-2028)
6.3 North America CD38 Monoclonal Antibody Drugs Market Size by Country
6.3.1 North America CD38 Monoclonal Antibody Drugs Sales by Country (2017-2028)
6.3.2 North America CD38 Monoclonal Antibody Drugs Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe CD38 Monoclonal Antibody Drugs Market Size by Type
7.1.1 Europe CD38 Monoclonal Antibody Drugs Sales by Type (2017-2028)
7.1.2 Europe CD38 Monoclonal Antibody Drugs Revenue by Type (2017-2028)
7.2 Europe CD38 Monoclonal Antibody Drugs Market Size by Application
7.2.1 Europe CD38 Monoclonal Antibody Drugs Sales by Application (2017-2028)
7.2.2 Europe CD38 Monoclonal Antibody Drugs Revenue by Application (2017-2028)
7.3 Europe CD38 Monoclonal Antibody Drugs Market Size by Country
7.3.1 Europe CD38 Monoclonal Antibody Drugs Sales by Country (2017-2028)
7.3.2 Europe CD38 Monoclonal Antibody Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific CD38 Monoclonal Antibody Drugs Market Size by Type
8.1.1 Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific CD38 Monoclonal Antibody Drugs Market Size by Application
8.2.1 Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific CD38 Monoclonal Antibody Drugs Market Size by Region
8.3.1 Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America CD38 Monoclonal Antibody Drugs Market Size by Type
9.1.1 Latin America CD38 Monoclonal Antibody Drugs Sales by Type (2017-2028)
9.1.2 Latin America CD38 Monoclonal Antibody Drugs Revenue by Type (2017-2028)
9.2 Latin America CD38 Monoclonal Antibody Drugs Market Size by Application
9.2.1 Latin America CD38 Monoclonal Antibody Drugs Sales by Application (2017-2028)
9.2.2 Latin America CD38 Monoclonal Antibody Drugs Revenue by Application (2017-2028)
9.3 Latin America CD38 Monoclonal Antibody Drugs Market Size by Country
9.3.1 Latin America CD38 Monoclonal Antibody Drugs Sales by Country (2017-2028)
9.3.2 Latin America CD38 Monoclonal Antibody Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa CD38 Monoclonal Antibody Drugs Market Size by Type
10.1.1 Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa CD38 Monoclonal Antibody Drugs Market Size by Application
10.2.1 Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa CD38 Monoclonal Antibody Drugs Market Size by Country
10.3.1 Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson
11.1.1 Johnson Corporation Information
11.1.2 Johnson Overview
11.1.3 Johnson CD38 Monoclonal Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson CD38 Monoclonal Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi CD38 Monoclonal Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi CD38 Monoclonal Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 Takeda Pharmaceutical Company
11.3.1 Takeda Pharmaceutical Company Corporation Information
11.3.2 Takeda Pharmaceutical Company Overview
11.3.3 Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Takeda Pharmaceutical Company Recent Developments
11.4 CASI Pharmaceutical Company
11.4.1 CASI Pharmaceutical Company Corporation Information
11.4.2 CASI Pharmaceutical Company Overview
11.4.3 CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 CASI Pharmaceutical Company Recent Developments
11.5 Mab Biopharma
11.5.1 Mab Biopharma Corporation Information
11.5.2 Mab Biopharma Overview
11.5.3 Mab Biopharma CD38 Monoclonal Antibody Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Mab Biopharma CD38 Monoclonal Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Mab Biopharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 CD38 Monoclonal Antibody Drugs Industry Chain Analysis
12.2 CD38 Monoclonal Antibody Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 CD38 Monoclonal Antibody Drugs Production Mode & Process
12.4 CD38 Monoclonal Antibody Drugs Sales and Marketing
12.4.1 CD38 Monoclonal Antibody Drugs Sales Channels
12.4.2 CD38 Monoclonal Antibody Drugs Distributors
12.5 CD38 Monoclonal Antibody Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 CD38 Monoclonal Antibody Drugs Industry Trends
13.2 CD38 Monoclonal Antibody Drugs Market Drivers
13.3 CD38 Monoclonal Antibody Drugs Market Challenges
13.4 CD38 Monoclonal Antibody Drugs Market Restraints
14 Key Findings in The Global CD38 Monoclonal Antibody Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global CD38 Monoclonal Antibody Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Daretuzumab
Table 3. Major Manufacturers of Isartuximab
Table 4. Major Manufacturers of Engineered Toxin Body
Table 5. Global CD38 Monoclonal Antibody Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global CD38 Monoclonal Antibody Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global CD38 Monoclonal Antibody Drugs Sales by Region (2017-2022) & (KG)
Table 8. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Region (2017-2022)
Table 9. Global CD38 Monoclonal Antibody Drugs Sales by Region (2023-2028) & (KG)
Table 10. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Region (2023-2028)
Table 11. Global CD38 Monoclonal Antibody Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Region (2017-2022)
Table 13. Global CD38 Monoclonal Antibody Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Region (2023-2028)
Table 15. Global CD38 Monoclonal Antibody Drugs Sales by Manufacturers (2017-2022) & (KG)
Table 16. Global CD38 Monoclonal Antibody Drugs Sales Share by Manufacturers (2017-2022)
Table 17. Global CD38 Monoclonal Antibody Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global CD38 Monoclonal Antibody Drugs Revenue Share by Manufacturers (2017-2022)
Table 19. CD38 Monoclonal Antibody Drugs Price by Manufacturers (2017-2022) &(US$/g)
Table 20. Global CD38 Monoclonal Antibody Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global CD38 Monoclonal Antibody Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD38 Monoclonal Antibody Drugs as of 2021)
Table 22. CD38 Monoclonal Antibody Drugs Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers CD38 Monoclonal Antibody Drugs Product Offered
Table 24. Date of Manufacturers Enter into CD38 Monoclonal Antibody Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global CD38 Monoclonal Antibody Drugs Sales by Type (2017-2022) & (KG)
Table 27. Global CD38 Monoclonal Antibody Drugs Sales by Type (2023-2028) & (KG)
Table 28. Global CD38 Monoclonal Antibody Drugs Sales Share by Type (2017-2022)
Table 29. Global CD38 Monoclonal Antibody Drugs Sales Share by Type (2023-2028)
Table 30. Global CD38 Monoclonal Antibody Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global CD38 Monoclonal Antibody Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global CD38 Monoclonal Antibody Drugs Revenue Share by Type (2017-2022)
Table 33. Global CD38 Monoclonal Antibody Drugs Revenue Share by Type (2023-2028)
Table 34. CD38 Monoclonal Antibody Drugs Price by Type (2017-2022) & (US$/g)
Table 35. Global CD38 Monoclonal Antibody Drugs Price Forecast by Type (2023-2028) & (US$/g)
Table 36. Global CD38 Monoclonal Antibody Drugs Sales by Application (2017-2022) & (KG)
Table 37. Global CD38 Monoclonal Antibody Drugs Sales by Application (2023-2028) & (KG)
Table 38. Global CD38 Monoclonal Antibody Drugs Sales Share by Application (2017-2022)
Table 39. Global CD38 Monoclonal Antibody Drugs Sales Share by Application (2023-2028)
Table 40. Global CD38 Monoclonal Antibody Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global CD38 Monoclonal Antibody Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global CD38 Monoclonal Antibody Drugs Revenue Share by Application (2017-2022)
Table 43. Global CD38 Monoclonal Antibody Drugs Revenue Share by Application (2023-2028)
Table 44. CD38 Monoclonal Antibody Drugs Price by Application (2017-2022) & (US$/g)
Table 45. Global CD38 Monoclonal Antibody Drugs Price Forecast by Application (2023-2028) & (US$/g)
Table 46. North America CD38 Monoclonal Antibody Drugs Sales by Type (2017-2022) & (KG)
Table 47. North America CD38 Monoclonal Antibody Drugs Sales by Type (2023-2028) & (KG)
Table 48. North America CD38 Monoclonal Antibody Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America CD38 Monoclonal Antibody Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America CD38 Monoclonal Antibody Drugs Sales by Application (2017-2022) & (KG)
Table 51. North America CD38 Monoclonal Antibody Drugs Sales by Application (2023-2028) & (KG)
Table 52. North America CD38 Monoclonal Antibody Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America CD38 Monoclonal Antibody Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America CD38 Monoclonal Antibody Drugs Sales by Country (2017-2022) & (KG)
Table 55. North America CD38 Monoclonal Antibody Drugs Sales by Country (2023-2028) & (KG)
Table 56. North America CD38 Monoclonal Antibody Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America CD38 Monoclonal Antibody Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe CD38 Monoclonal Antibody Drugs Sales by Type (2017-2022) & (KG)
Table 59. Europe CD38 Monoclonal Antibody Drugs Sales by Type (2023-2028) & (KG)
Table 60. Europe CD38 Monoclonal Antibody Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe CD38 Monoclonal Antibody Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe CD38 Monoclonal Antibody Drugs Sales by Application (2017-2022) & (KG)
Table 63. Europe CD38 Monoclonal Antibody Drugs Sales by Application (2023-2028) & (KG)
Table 64. Europe CD38 Monoclonal Antibody Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe CD38 Monoclonal Antibody Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe CD38 Monoclonal Antibody Drugs Sales by Country (2017-2022) & (KG)
Table 67. Europe CD38 Monoclonal Antibody Drugs Sales by Country (2023-2028) & (KG)
Table 68. Europe CD38 Monoclonal Antibody Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe CD38 Monoclonal Antibody Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Type (2017-2022) & (KG)
Table 71. Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Type (2023-2028) & (KG)
Table 72. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Application (2017-2022) & (KG)
Table 75. Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Application (2023-2028) & (KG)
Table 76. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Region (2017-2022) & (KG)
Table 79. Asia Pacific CD38 Monoclonal Antibody Drugs Sales by Region (2023-2028) & (KG)
Table 80. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America CD38 Monoclonal Antibody Drugs Sales by Type (2017-2022) & (KG)
Table 83. Latin America CD38 Monoclonal Antibody Drugs Sales by Type (2023-2028) & (KG)
Table 84. Latin America CD38 Monoclonal Antibody Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America CD38 Monoclonal Antibody Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America CD38 Monoclonal Antibody Drugs Sales by Application (2017-2022) & (KG)
Table 87. Latin America CD38 Monoclonal Antibody Drugs Sales by Application (2023-2028) & (KG)
Table 88. Latin America CD38 Monoclonal Antibody Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America CD38 Monoclonal Antibody Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America CD38 Monoclonal Antibody Drugs Sales by Country (2017-2022) & (KG)
Table 91. Latin America CD38 Monoclonal Antibody Drugs Sales by Country (2023-2028) & (KG)
Table 92. Latin America CD38 Monoclonal Antibody Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America CD38 Monoclonal Antibody Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Type (2017-2022) & (KG)
Table 95. Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Type (2023-2028) & (KG)
Table 96. Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Application (2017-2022) & (KG)
Table 99. Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Application (2023-2028) & (KG)
Table 100. Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Country (2017-2022) & (KG)
Table 103. Middle East and Africa CD38 Monoclonal Antibody Drugs Sales by Country (2023-2028) & (KG)
Table 104. Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 106. Johnson Corporation Information
Table 107. Johnson Description and Major Businesses
Table 108. Johnson CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 109. Johnson CD38 Monoclonal Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Johnson Recent Developments
Table 111. Sanofi Corporation Information
Table 112. Sanofi Description and Major Businesses
Table 113. Sanofi CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 114. Sanofi CD38 Monoclonal Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Sanofi Recent Developments
Table 116. Takeda Pharmaceutical Company Corporation Information
Table 117. Takeda Pharmaceutical Company Description and Major Businesses
Table 118. Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 119. Takeda Pharmaceutical Company CD38 Monoclonal Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Takeda Pharmaceutical Company Recent Developments
Table 121. CASI Pharmaceutical Company Corporation Information
Table 122. CASI Pharmaceutical Company Description and Major Businesses
Table 123. CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 124. CASI Pharmaceutical Company CD38 Monoclonal Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. CASI Pharmaceutical Company Recent Developments
Table 126. Mab Biopharma Corporation Information
Table 127. Mab Biopharma Description and Major Businesses
Table 128. Mab Biopharma CD38 Monoclonal Antibody Drugs Sales (KG), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 129. Mab Biopharma CD38 Monoclonal Antibody Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Mab Biopharma Recent Developments
Table 131. Key Raw Materials Lists
Table 132. Raw Materials Key Suppliers Lists
Table 133. CD38 Monoclonal Antibody Drugs Distributors List
Table 134. CD38 Monoclonal Antibody Drugs Customers List
Table 135. CD38 Monoclonal Antibody Drugs Market Trends
Table 136. CD38 Monoclonal Antibody Drugs Market Drivers
Table 137. CD38 Monoclonal Antibody Drugs Market Challenges
Table 138. CD38 Monoclonal Antibody Drugs Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. CD38 Monoclonal Antibody Drugs Product Picture
Figure 3. Global CD38 Monoclonal Antibody Drugs Market Share by Type in 2021 & 2028
Figure 3. Daretuzumab Product Picture
Figure 4. Isartuximab Product Picture
Figure 5. Engineered Toxin Body Product Picture
Figure 6. Global CD38 Monoclonal Antibody Drugs Market Share by Application in 2021 & 2028
Figure 7. Multiple Myeloma
Figure 8. Diffuse Large B Cell Lymphoma
Figure 9. Other
Figure 10. CD38 Monoclonal Antibody Drugs Report Years Considered
Figure 11. Global CD38 Monoclonal Antibody Drugs Sales 2017-2028 (KG)
Figure 12. Global CD38 Monoclonal Antibody Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global CD38 Monoclonal Antibody Drugs Revenue 2017-2028 (US$ Million)
Figure 14. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Region (2017-2022)
Figure 16. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Region (2023-2028)
Figure 17. North America CD38 Monoclonal Antibody Drugs Sales YoY (2017-2028) & (KG)
Figure 18. North America CD38 Monoclonal Antibody Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe CD38 Monoclonal Antibody Drugs Sales YoY (2017-2028) & (KG)
Figure 20. Europe CD38 Monoclonal Antibody Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific CD38 Monoclonal Antibody Drugs Sales YoY (2017-2028) & (KG)
Figure 22. Asia-Pacific CD38 Monoclonal Antibody Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America CD38 Monoclonal Antibody Drugs Sales YoY (2017-2028) & (KG)
Figure 24. Latin America CD38 Monoclonal Antibody Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa CD38 Monoclonal Antibody Drugs Sales YoY (2017-2028) & (KG)
Figure 26. Middle East & Africa CD38 Monoclonal Antibody Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The CD38 Monoclonal Antibody Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of CD38 Monoclonal Antibody Drugs in the World: Market Share by CD38 Monoclonal Antibody Drugs Revenue in 2021
Figure 29. Global CD38 Monoclonal Antibody Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global CD38 Monoclonal Antibody Drugs Sales Market Share by Application (2017-2028)
Figure 33. Global CD38 Monoclonal Antibody Drugs Revenue Market Share by Application (2017-2028)
Figure 34. North America CD38 Monoclonal Antibody Drugs Sales Market Share by Type (2017-2028)
Figure 35. North America CD38 Monoclonal Antibody Drugs Revenue Market Share by Type (2017-2028)
Figure 36. North America CD38 Monoclonal Antibody Drugs Sales Market Share by Application (2017-2028)
Figure 37. North America CD38 Monoclonal Antibody Drugs Revenue Market Share by Application (2017-2028)
Figure 38. North America CD38 Monoclonal Antibody Drugs Sales Share by Country (2017-2028)
Figure 39. North America CD38 Monoclonal Antibody Drugs Revenue Share by Country (2017-2028)
Figure 40. United States CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Canada CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 42. Europe CD38 Monoclonal Antibody Drugs Sales Market Share by Type (2017-2028)
Figure 43. Europe CD38 Monoclonal Antibody Drugs Revenue Market Share by Type (2017-2028)
Figure 44. Europe CD38 Monoclonal Antibody Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe CD38 Monoclonal Antibody Drugs Revenue Market Share by Application (2017-2028)
Figure 46. Europe CD38 Monoclonal Antibody Drugs Sales Share by Country (2017-2028)
Figure 47. Europe CD38 Monoclonal Antibody Drugs Revenue Share by Country (2017-2028)
Figure 48. Germany CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. France CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Italy CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. Russia CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific CD38 Monoclonal Antibody Drugs Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific CD38 Monoclonal Antibody Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific CD38 Monoclonal Antibody Drugs Sales Share by Region (2017-2028)
Figure 58. Asia Pacific CD38 Monoclonal Antibody Drugs Revenue Share by Region (2017-2028)
Figure 59. China CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Japan CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. India CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Australia CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America CD38 Monoclonal Antibody Drugs Sales Market Share by Type (2017-2028)
Figure 69. Latin America CD38 Monoclonal Antibody Drugs Revenue Market Share by Type (2017-2028)
Figure 70. Latin America CD38 Monoclonal Antibody Drugs Sales Market Share by Application (2017-2028)
Figure 71. Latin America CD38 Monoclonal Antibody Drugs Revenue Market Share by Application (2017-2028)
Figure 72. Latin America CD38 Monoclonal Antibody Drugs Sales Share by Country (2017-2028)
Figure 73. Latin America CD38 Monoclonal Antibody Drugs Revenue Share by Country (2017-2028)
Figure 74. Mexico CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina CD38 Monoclonal Antibody Drugs Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa CD38 Monoclonal Antibody Drugs Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa CD38 Monoclonal Antibody Drugs Revenue Market

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs